Name | N'-(3-hydroxy-10,13-dimethyl-3,4,7,8,9,11,12,13,15,16-decahydro-1H-cyclopenta[a]phenanthren-17(2H,10H,14H)-ylidene)-4-methylbenzenesulfonohydrazide |
---|---|
Synonyms |
5alpha-Spirost-9(11)-en-3beta-ol,(25R)
5-dehydroepiandrosterone p-toluenesulfonyl hydrazone |
Density | 1.33g/cm3 |
---|---|
Boiling Point | 606.4ºC at 760mmHg |
Molecular Formula | C26H36N2O3S |
Molecular Weight | 456.64100 |
Flash Point | 320.5ºC |
Exact Mass | 456.24500 |
PSA | 87.14000 |
LogP | 6.42470 |
~97% 34988-34-6 |
Literature: CRYSTAL PHARMA, S.A.U.; Perez Encabo, Alfonso; Turiel Hernandez, Jose Angel; Gallo Nieto, Francisco Javier; Lorente Bonde-Larsen, Antonio; Sandoval Rodriguez, Celso Miguel Patent: US2014/11992 A1, 2014 ; Location in patent: Paragraph 0201; 0202; 0203 ; |
Precursor 2 | |
---|---|
DownStream 1 | |